Clearmind Medicine Inc. Annual Research And Development Expense in USD from 2021 to 2023

Taxonomy & unit
ifrs-full: CAD and USD
Summary
Clearmind Medicine Inc. quarterly/annual Research And Development Expense history and growth rate from 2021 to 2023.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending January 31, 2024 was $227K, a 61.3% decline year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2023 was $1.54M, a 49.9% decline from 2022.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2022 was $3.08M, a 550% increase from 2021.
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.54M -$1.54M -49.9% Nov 1, 2022 Oct 31, 2023 20-F/A 2024-03-18
2022 $3.08M +$2.61M +550% Nov 1, 2021 Oct 31, 2022 20-F/A 2024-03-18
2021 $474K Nov 1, 2020 Oct 31, 2021 20-F/A 2024-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.